Swine flu (H1N1) vaccine for children
This page includes information about swine flu (H1N1) vaccination for children aged over 6 months
On December 3 2009 Australia's medicines regulator, the Therapeutic Goods Administration (TGA), approved the use of Panvax H1N1 influenza vaccine to include children aged from 6 months of age.
In addition, the TGA also approved Panvax H1N1 Junior influenza vaccine specifically for use in children aged from 6 months up to 3 years of age.
The TGA approved the use of Panvax H1N1 influenza vaccine in children, and Panvax H1N1 Junior, following analysis of paediatric clinical trial data.
The TGA approved Panvax H1N1 influenza vaccine on 18 September 2009 for use in adults and children over 10 years of age.
Panvax H1N1 influenza vaccine and Panvax H1N1 Junior are manufactured by the Australian company, CSL Limited, using the same processes as those used to manufacture seasonal influenza vaccines.
Panvax for children forms
Please follow this link to the swine flu forms page on this website
Adverse events reporting
Healthcare practitioners and families are encouraged to report any side effects by telephoning 18 02 007 or the online reporting form available from the TGA website:
tga.gov.au/problem/panvaxh1n1.htm
More information